Florida Plans to Scrap Kid Vaccine Mandates as HHS Employees Demand RFK Jr Resignation

HHS Employees Call for Kennedy’s Resignation
In other developments today, more than 1,000 current and former HHS staff released a letter calling for Kennedy to resign. The letter is separate from but builds on an August 20 letter that HHS employees released after the August 8 armed attack on CDC headquarters that has now been cosigned by 6,370 people, 887 of them from HHS.

The new letter, posted on the Save HHS website, said Kennedy continues to endanger the public’s health by facilitating the firing of the CDC’s newly confirmed Director Susan Monarez, PhD, prompting the resignations of three top CDC scientists, and appointing ideologues, mostly without scientific credentials, to manipulate vaccine data to fit predetermined conclusions.

In the letter, the group also said Kennedy is disregarding the Trump Administration’s own “gold standard” scientific policy, has rolled back COVID vaccine availability without providing evidence to back the policy changes, and has disparaged the HHS workforce by claiming that trusting experts is not a feature of either a science or democracy.

Should he decline to resign, we call upon the President and U.S. Congress to appoint a new Secretary of Health and Human Services, one whose qualifications and experience ensure that health policy is informed by independent and unbiased peer-reviewed science,” the group wrote. “We expect those in leadership to act when the health of Americans is at stake.”

________________________________________

“Should he decline to resign, we call upon the President and U.S. Congress to appoint a new Secretary of Health and Human Services.”

________________________________________

Some lawmakers have pressed for Kennedy to appear before the Senate Health, Education, Labor and Pensions (HELP) committee to defend his recent actions. So far, no HELP committee hearing has been scheduled, but tomorrow Kennedy will testify before the Senate Finance Committee to discuss MAHA actions and plans for the future.  It’s unclear if the committee will ask Kennedy about the shakeup at the CDC or other recent actions, especially regarding vaccines.

FDA Questions Vaccine Coadministration, Ousts Kennedy Critic from Panel
Meanwhile, several other developments regarding federal vaccine policy have made news headlines over the past day.

New leadership at the Food and Drug Administration (FDA), including Kennedy allies, are questioning the safety of co-administering flu and COVID vaccines, the Washington Post reported today. Giving both vaccines at the same time has been recommended as an option to ease the uptake of both vaccines ahead of the winter respiratory virus season. No safety signals have been reported, and studies have not shown that the practice erodes the benefit of either vaccine.

Officials announced that vaccine companies must conduct new clinical trials before claiming that co-administering the vaccines is safe and effective.

Also, Paul Offit, MD, an infectious disease specialist at Children’s Hospital of Philadelphia, has been removed the FDA’s vaccine advisory committee, Endpoints News reported yesterday. In an email, Offit told Endpoints that he wasn’t given a reason for his dismissal from the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC). He was serving the last of his two 4-year terms and had 2 years remaining on his appointment. 

Offit’s ouster is the latest in HHS efforts to sideline expert committees or stack them with people who align with Kennedy’s priorities. Offit on his Substack blog has been a frequent critic of Kennedy’s policies regarding vaccines.

Lisa Schnirring is news editor at CIDRAP. This article is published courtesy of the University of Minnesota’s Center for Infectious Diseases Research and Policy (CIDRAP).

Leave a comment

Register for your own account so you may participate in comment discussion. Please read the Comment Guidelines before posting. By leaving a comment, you agree to abide by our Comment Guidelines, our Privacy Policy, and Terms of Use. Please stay on topic, be civil, and be brief. Names are displayed with all comments. Learn more about Joining our Web Community.